Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print.
BackgroundPulmonary arterial hypertension is controlled by the dual endothelin receptor antagonist bosentan monohydrate. Recent advances in microneedle technology offer controlled, prolonged drug release.PurposeThis study formulated and evaluated a …